For Professional
ECMT-154™: Backed by Science, Powered by Nature
Discover the future of botanical dermatology with ECMT-154™, a proprietary therapeutic extract developed by Manuka Bioscience using potent East Cape manuka oil. This clinically backed active is revolutionising how we approach skin infections, wound care, acne, inflammation, and skin barrier repair.
Why dermatologists are taking notice:
- Antibacterial efficacy against S. aureus, MRSA, and S. pyogenes — outperforming Betadine and matching Fucidin
- Anti-acne power greater than Benzac and Clearasil against C. acnes and S. epidermidis
- Proven wound healing, antioxidant, and skin barrier restoration properties
- Clinically tested, hypoallergenic, and suitable for post-procedural care
Whether you're addressing acne-prone skin, chronic infections, or skin barrier impairment, ECMT-154™ offers a natural yet clinically robust solution your patients will appreciate.
DM Endorsement
“My patients love that I can provide them with a natural product. We both love how well it works to clear up their complexions. I’ve found it works particularly well for hormonal-induced skin changes.”
Candace Spann, MD-Board Certified Dermatologist
“What I’m most impressed with are the studies showing how effective the active ingredient is against the bacteria that cause skin blemishes. It’s great to have a system with a potent natural compound that works effectively and is gentle on the skin.”
Mark J. Tager, MD- Integrative Health Practitioner
Clinically Tested. Dermatologist Trusted.
Rejencia's Blemish Kit isn’t just skincare, it’s science-backed skincare.
In a 14-day independent clinical test, our full blemish-fighting regimen was put head-to-head against a placebo. The results speak volumes.
Proven Results After Just 2 Weeks*:
- Pore size visibly reduced — reflecting improved skin texture and clarity
- Significant decrease in acne and inflammation, even in sensitive skin
- Sebum production reduced, helping control oily skin and prevent future breakouts
*The test involved 30 female participants across two controlled groups, using advanced measurement tools (DermaLab Combo, ASW 300, NATI V3). Conducted by SKINLAB P.S.A. Laboratory, this study provides strong evidence of Rejencia’s clinical performance.